Vertex Pharmaceuticals Incorporated
VRTX
$448.29
$13.123.02%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -6.37% | 3.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.37% | 3.69% | |||
| Cost of Revenue | -5.92% | 3.39% | |||
| Gross Profit | -6.73% | 3.94% | |||
| SG&A Expenses | 1.38% | 9.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.08% | 4.85% | |||
| Operating Income | -9.86% | 1.98% | |||
| Income Before Tax | -5.87% | 2.48% | |||
| Income Tax Expenses | 58.33% | -35.20% | |||
| Earnings from Continuing Operations | -13.41% | 9.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.41% | 9.99% | |||
| EBIT | -9.86% | 1.98% | |||
| EBITDA | -7.23% | -0.39% | |||
| EPS Basic | -13.48% | 10.73% | |||
| Normalized Basic EPS | -9.58% | 2.77% | |||
| EPS Diluted | -13.54% | 10.70% | |||
| Normalized Diluted EPS | -9.58% | 2.68% | |||
| Average Basic Shares Outstanding | 0.08% | -0.67% | |||
| Average Diluted Shares Outstanding | 0.08% | -0.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||